First Foundation Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,377
| Closed | -$327K | – | 393 |
|
|
2022
Q4 | $327K | Sell |
1,377
-521
| -27% | -$124K | 0.02% | 294 |
|
|
2022
Q3 | $380K | Sell |
1,898
-1,568
| -45% | -$314K | 0.02% | 260 |
|
|
2022
Q2 | $506K | Sell |
3,466
-8,568
| -71% | -$1.25M | 0.02% | 249 |
|
|
2022
Q1 | $1.97M | Sell |
12,034
-2,430
| -17% | -$397K | 0.07% | 135 |
|
|
2021
Q4 | $2.45M | Buy |
14,464
+600
| +4% | +$102K | 0.08% | 119 |
|
|
2021
Q3 | $2.62M | Buy |
13,864
+1,035
| +8% | +$195K | 0.1% | 110 |
|
|
2021
Q2 | $2.18M | Buy |
12,829
+1,155
| +10% | +$196K | 0.08% | 135 |
|
|
2021
Q1 | $1.65M | Buy |
+11,674
| New | +$1.65M | 0.07% | 152 |
|